Effect of a Medication Reminder Mobile Application
NCT06477068 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 387
Last updated 2026-04-29
Summary
The goal of this clinical trial is to evaluate of effectiveness when using the "telemedicine medication reminder app on smartphones" at the Infertility Department of Hung Vuong Hospital. The main questions it aims to answer are:
Comparison of the medication forgetting rate between the group of patients using the product and the group of patients not using the app.
Assessment of the level of patient satisfaction when using the app. Comparison of the quantity and quality outcomes of eggs between the group of patients using the app and the group of patients not using the app.
Participants will:
Using or not using " "telemedicine medication reminder app on smartphones" Record the number of cycle cancellations, number of missed doses, satisfaction rates, number of retrieved oocytes, number of mature oocytes, number of immature oocytes, and number of abnormal oocytes.
Conditions
Interventions
- COMBINATION_PRODUCT
-
Mobile medical reminder application
Experimental group: Patients undergoing ovarian stimulation in the Infertility Department at Hung Vuong Hospital are prescribed and instructed to inject medication according to the current procedure of the department, in addition to being supported through the "telemedicine medication reminder app on smartphones". Control group: Patients undergoing ovarian stimulation in the Infertility Department at Hung Vuong Hospital are prescribed and instructed to inject medication according to the current procedure of the department.
Sponsors & Collaborators
-
Hung Vuong Hospital
lead OTHER
Principal Investigators
-
Le-Giang Tran, Ph.D. · International University, Vietnam National University - Hochiminh City
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-05-22
- Primary Completion
- 2026-03-09
- Completion
- 2026-04-22
Countries
- Vietnam
Study Locations
More Related Trials
-
GnRH Agonist Versus hCG Trigger in Ovulation Induction With Intrauterine Insemination.
NCT03825445 ·Status: COMPLETED ·Phase: NA
-
Administration of Methylprednisolone for Prevention of Ovarian Hyper Stimulation Syndrome
NCT01014104 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal Micronized Progesterone Tablet (Endometrin®) Compared to Crinone 8% Vaginal Gel in Female Patients Undergoing In-Vitro Fertilization (IVF)
NCT00296478 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Effectiveness of Progestin-Primed Versus GnRH Antagonist Protocols in Vietnamese Women Undergoing In-vitro Fertilization
NCT06191809 ·Status: RECRUITING ·Phase: NA
-
Optimal Stimulation of Hypo-responders Undergoing in Vitro Fertilization (IVF)
NCT07121751 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Prolonged Protocol of Early Follicular or Mid Luteal Phase
NCT04522479 ·Status: UNKNOWN ·Phase: NA
-
HRT Versus MOS for Endometrial Preparation Prior to FET in Non PCOS Patients
NCT02330757 ·Status: RECRUITING ·Phase: PHASE4
-
Early Luteal Hormones and IVF Outcomes After hCG Triggering
NCT04693624 ·Status: COMPLETED
-
Trigger Timing in Ovarian Stimulations
NCT04163133 ·Status: RECRUITING ·Phase: NA
-
An Advanced Decision Support Tool, Opt-IVF for Clinical Ivf Practice
NCT05564702 ·Status: COMPLETED ·Phase: NA
-
A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation
NCT00298025 ·Status: COMPLETED ·Phase: PHASE4
-
Extended Letrozole Regimen Co-treatment With Gonadotropin Releasing Hormone Antagonist Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in Poor Responders Undergoing IVF-ET
NCT04268927 ·Status: UNKNOWN ·Phase: PHASE2
-
GnRH Agonist Pretreatment Duration and Letrozole Supplementation in Frozen Embryo Transfer for Adenomyosis Patients
NCT07065539 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Multicenter, Randomized, Open Label, Parallel Study to Evaluate the Efficacy & Safety of IVF-M HP Inj. vs. Menopur® Inj.
NCT02458768 ·Status: COMPLETED ·Phase: PHASE4
-
Levels of Anti-Mullerian Hormone (AMH) During Ovarian Stimulation With Gonadotropins
NCT02237781 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Effects of Intrauterine Infusion of hCG at the Time of Embryo Transfer
NCT02668965 ·Status: UNKNOWN ·Phase: NA
-
Early Luteal Progesterone Profile After hCG Triggering
NCT02798146 ·Status: COMPLETED ·Phase: NA
-
The Effect of LH-Priming During Early Follicular Phase in IVF Treatment.
NCT00334425 ·Status: UNKNOWN ·Phase: PHASE4
-
Gonadotrophin Releasing Hormone Agonist Addition for Luteal Support in In-vitro Fertilization and Embryo Transfer Cycles
NCT02908438 ·Status: UNKNOWN ·Phase: PHASE1
-
The Value of Addition of Human Menopausal Gonadotropin Drug Following Oocytes Retrieval in IVF Cycles
NCT03209687 ·Status: COMPLETED ·Phase: PHASE4
-
Intrauterine Injection of Human Chorionic Gonadotropin Before Embryo Transfer in Women With Previous IVF Failure
NCT02329197 ·Status: UNKNOWN ·Phase: PHASE4
-
PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study)
NCT06378268 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Corifollitropin Alfa Followed by Menotropin for Poor Ovarian Responders Trial
NCT01816321 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective Randomized Multicentre Study to Compare Crinone 8% Once Daily Versus Other Vaginal Progesterone.
NCT00708539 ·Status: UNKNOWN ·Phase: PHASE4
-
GnRHa Trigger in Asian Oocyte Donors- a Dose Finding Study
NCT02208986 ·Status: COMPLETED ·Phase: NA